Preclinical In Vivo Research in Mispro Facilities
Purpose-built for next-generation therapeutics
Mispro offers research-ready environments for rigorous non-GLP in vivo studies across modalities and indications, enabling teams to generate reproducible, decision-grade data.
In Vivo Pharmacology & Translational Research
Mispro's research environments support early-stage non-GLP pharmacology, efficacy, and safety assessment studies in murine (mice) and rat models within controlled BSL-1 and BSL-2 environments. Stable environmental parameters and integrated veterinary oversight strengthen reproducibility and downstream data interpretation. Common research applications include:
Therapeutic Modalities & Drug Delivery
Mispro supports advanced and emerging therapeutic modalities within biosecure, environmentally controlled, AAALAC-accredited vivarium environments aligned with pharmaceutical diligence expectations. These conditions support scientific integrity across complex and evolving platforms, including:
Additional Fields of Research
In addition to core translational programs, Mispro environments support a wide spectrum of therapeutic disciplines and organ-system–based research, enabling rigorous in vivo investigation across diverse disease biology, including:
High-Impact Areas
Explore how Mispro’s AAALAC-accredited environments are specifically designed to support complex in vivo research across high-impact therapeutic areas, with infrastructure, services and oversight specifically designed to sustain reproducibility and translational rigor.
Oncology
Mispro provides controlled environments for in vivo oncology studies including tumor models, immuno-oncology, and therapeutic efficacy research.
Neurology, Psychiatry & Substance Use Disorder
Mispro provides the space and privacy required for behavioral and CNS-focused in vivo studies in neurology, psychiatry, and addiction research.
Immunology & Vaccines
Mispro's AAALAC-accredited facilities provide stable environments for in vivo immunology, inflammatory disease, and vaccine research.
Cell & Gene Therapy / Editing
Mispro is the right choice for CGT programs requiring controlled environments for complex and parallel in vivo study designs.
Innovation Across Our Network
- 88% Novel / Proprietary Research
- 58% Translational Programs
- 46% Platform Companies
- 75% Of biotech M&A activity in 2025
What Our Clients Say
"Mispro provides a supportive, collaborative environment for in vivo research—just minutes from our lab. Their technical services team expertly handled a complex dosing procedure on our behalf, enabling high-quality preclinical studies with data we can trust. With Mispro’s support, we’re achieving critical milestones that are advancing our program—and our company—closer to the next stage."
Director of R&D, HydroGene Therapeutics
"Our experience working with Mispro has been really great. Both the facility supervisor and the IACUC coordinator have been a great help to our team. From the set-up of our rooms to managing the daily needs for our animal studies, to helping with our animal protocols, their level of service is commendable."
Sr. Scientist, KalVista
"Conducting our studies in Mispro’s contract vivarium has been a highly effective solution. Their flexible space options, experienced IACUC, and dedicated animal care staff have directly added value to our preclinical program and the quality of our animal studies."
In Vivo Scientist, Shinobi Therapeutics, Inc.
"Mispro has carefully and expertly designed both its facility and supporting services to enable researchers to conduct studies with precision and confidence. We’ve doubled our in vivo capacity in less than a year as a result of our success in Mispro’s research environment."
Group Leader, GenEdit
Ready to Talk to Our Team?
From regulatory questions to technical requirements, our team has fielded it before. Let's talk.